A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and design

By afschroeder • March 31, 2026

Wazni OM, Chun KJ, Amin A, Anic A, Ajijola OA, Gibson DN, Mansour M, Makati K, Chrispin J, Duytschaever M, Nair DG, Piccini JP, Natale A, Raciti G, Wehrenberg S, McCammon S, Albrecht EM, Garlitski A, Sutton BS, Andrade JG; AVANT GUARD Investigators. A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and design. Heart Rhythm O2. 2025 Dec 23;7(3):561-574. doi: 10.1016/j.hroo.2025.12.011. PMID: 41908201; PMCID: PMC13031045.

Tags: antiarrhythmic drugs, Cardiology/Epi, catheter ablation, First-line therapy, persistent atrial fibrillation, Publications, pulsed field ablation, Randomized Controlled Trial

Regional heterogeneity and sex differences along the mouse aorta

Sveeggen TM, Kosmach A, Mitchell R, Brockmann BC, Meisinger TM, Stratman AN, Mack JJ, Cook JR, Bagher P. Regional heterogeneity and sex differences along the[...]

Cost Offset With Quadruple Therapy for Heart Failure

Keykhaei M, Rashedi S, Greene SJ, Yancy C, Ziaeian B, Sandhu AT, Kittleson M, Fonarow GC. Cost Offset With Quadruple Therapy for Heart Failure. JAMA[...]

Mapping of Incisional Reentrant Tachycardia: Lesson Learned

Baskar S, Moore JP. Mapping of Incisional Reentrant Tachycardia: Lesson Learned. Indian Pacing Electrophysiol J. 2026 Jun 10:S0972-6292(26)00136-1. doi: 10.1016/j.ipej.2026.06.005. Epub ahead of print. PMID:[...]